DEV — test website with test data. Orders here are not real and nothing is shipped or charged.

Tech support 866-350-1500

Pay by PO: enter it at checkout

Neuromics

Publications

Published research that used Neuromics reagents, with the products each paper cites. Search, or narrow by product family and year.

Papers
672
Products cited
176

Papers that used GFAP (RA22101)Show all products

9 of 672 papers

  1. Artificial Intelligence-Driven Drug Repositioning Uncovers Efavirenz as a Modulator of α-Synuclein Propagation: Implications in Parkinson’s Disease

    Jae-Bong Kim, Soo-Jeong Kim, Minyoung So, Dong-Kyu Kim, Hye Rin Noh, Beom Jin Kim, Yu Ree Choi, Doyoon Kim, Heejung Koo, Taeyong Kim, Hyun Goo Woo, and Sang Myun Park · Biomedicine & Pharmacotherapy, 174:116442 · 2024

    Products used

    • GFAPRA22101 · 100 ul$303.00
  2. Exposure to an Enriched Environment Modulates the Synaptic Vesicle Cycle in a Mouse Spinal Cord Injury Model

    Jeehyun Yoo, Ji Cheol Shin, Kil-Byung Lim, Se Hoon Kim, Hyun Seok Kim, Sung Hoon Kim, Dawoon Baek, Seongmoon Jo, Jinyoung Kim, Ahreum Baek, and Sung-Rae Cho · Scientific Reports, 14:11946 · 2024

    Products used

    • GFAPRA22101 · 100 ul$303.00
  3. Uncovering the Role of c-Fos in the Bidirectional Relationship Between Depression/Anxiety Behaviors and α-Synuclein Propagation in Parkinson's Disease

    Soo-Jeong Kim, Jae-Bong Kim, Seonghui Ham, and Sang Myun Park · Research Square · 2024

    Products used

    • GFAPRA22101 · 100 ul$303.00
  4. Integration of National Health Insurance Claim Data and Animal Models Reveals Fexofenadine as a Promising Repurposed Drug for Parkinson’s Disease

    Jae-Bong Kim, Yujeong Kim, Soo-Jeong Kim, Tae‑Young Ha, Dong-Kyu Kim, Dong Won Kim, Minyoung So, Seung Ho Kim, Hyun Goo Woo, Dukyong Yoon, and Sang Myun Park · Research Square · 2023

    Products used

    • GFAPRA22101 · 100 ul$303.00
  5. BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort

    M. Vassilakopoulou, M. Won, W.J. Curran, L. Souhami, M.D. Prados, C.J. Langer, D.L. Rimm, J.A. Hanna, V.M. Neumeister, E. Melian, A.Z. Diaz, J.N. Atkins, L.T. Komarnicky, C.J. Schultz, S.P. Howard, P. Zhang, A.P. Dicker, and J.P.S. Knisely · Oncology: 1-9 · 2021

    Products used

    • GFAPRA22101 · 100 ul$303.00
  6. Interaction Between Coxsackievirus B3 Infection and α-Synuclein in Models of Parkinson’s Disease

    Soo Jin Park, Uram Jin, and Sang Myun Park · PLoS Pathogens, 17(10): e1010018 · 2021

    Products used

    • GFAPRA22101 · 100 ul$303.00
  7. The Novel DYRK1A Inhibitor KVN93 Regulates Cognitive Function, Amyloid-Beta Pathology, and Neuroinflammation

    Hyun-Ju Lee, Hanwoong Woo, Ha-Eun Lee, Hyongjun Jeon, Ka-Young Ryu, Jin Han Nam, Seong Gak Jeon, Hyun Hee Park, Ji-Soo Lee, Kyung-Min Han, Sang Min Lee, Jeongyeon Kim, Ri-Jin Kang, Young-Ho Lee, Jae-Ick Kim, Hyang-Sook Hoe · Free Radical Biology and Medicine · 2020

    Products used

    • GFAPRA22101 · 100 ul$303.00
  8. Functional Crosstalk Between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson’s Disease

    Rayul Wi, Young Cheul Chung, and Byung Kwan Jin · Journal of Immunology Research · 2020

    Products used

    • GFAPRA22101 · 100 ul$303.00
  9. Qi-Activating Quercetin Alleviates Mitochondrial Dysfunction and Neuroinflammation In Vivo and In Vitro

    Sora Kang, Ying Piao, Young Cheol Kang, Suyeol Lim, and Youngmi Kim Pak · Archives of Pharmacal Research · 2020

    Products used

    • GFAPRA22101 · 100 ul$303.00